Formulary

Anti-Cellulite Body Lotion

Released by Evonik Corporation - Personal Care business line

January 1, 2011


Phase A
Tego Care LTP (Evonik) (Sorbitan laurate; polyglyceryl- 4 laurate; dilauryl citrate)
1.50
Tegosoft CI (Evonik) (Cetearyl isononanoate)
10.00
Tegosoft DEC (Evonik) (Diethylhexyl carbonate)
3.50
Tegosoft OP (Evonik) (Ethylhexyl palmitate)
1.10
Tego Xymenynic (Evonik) (Caprylic/capric triglyceride; xymenynic acid (proposed))
2.00
Tego Carbomer 140 (Evonik)
0.15
Tego Carbomer 141 (Evonik)
0.15
Xanthan gum
0.10
Glycerin
3.00
Water
77.50

Phase B
Caffeine
1.00

Phase C
Sodium hydroxide (10% in water)
q.s.

Phase Z
Preservative, perfume
q.s.

Procedure
Mix ingredients of phase A. Combine phases A and B without stirring. Homogenize. Add phases C and Z and stir well.

More Information
Evonik Goldschmidt GmbH, Tel: +49 201 173-2854; Fax: +49 201 173-1828u2028; Email: personal-care@evonik.com; Website: www.evonik.com/personal-care

Related End-User Markets:

  • The World Comes to Orlando

    The World Comes to Orlando

    Tom Branna , Editorial Director||December 1, 2016
    More than 1,600 chemists traveled to Florida for the IFSCC Congress

  • Perform or Perish

    Perform or Perish

    Christine Esposito, Associate Editor||December 1, 2016
    Success in today’s skin care sector begins with active ingredients, formulated in products that address modern-day issues.

  • Soap Opera

    Soap Opera

    Christine Esposito, Associate Editor||November 2, 2016
    FDA’s recent antibacterial ruling has soap sector stakeholders scrambling to keep some ingredients in their formulation kit.